Matthew Herper on Muck Rack

Matthew Herper Verified

New York
Senior Editor — Forbes
As seen in: Forbes

Forbes reporter covering science and medicine

Tasting The Fake Meat That Wants To Save The World

How Focusing On Obscure Diseases Made BioMarin A $15 Billion Company

forbes.com — BioMarin became one of the world's most valuable biotechs by jettisoning costly distractions and focusing on one thing: treating some of the rarest diseases on the planet.

The Country's Biggest Biotechs

forbes.com — Biotechnology firms are a small but growing sector of the pharmaceutical industry. As of May 18, 2016, these are the ten biggest.

BioMarin Gene Therapy Yields Dramatic Results In Hemophilia

forbes.com — A new gene therapy for hemophilia, a deadly disease in which blood does not clot, may allow most patients to live normal lives, escaping frequent infusions needed for current treatments and almost unavoidable damage to their joints caused by internal bleeding. The results, presented at the annual meeting of the World [...]

Alzheimer's Maverick TauRx Tries To Weave Success From Failed Trial

forbes.com — TauRx, a privately held drug company in Singapore that has focused on a daring alternative approach to attacking Alzheimer's disease, released results this morning of an 891-patient study of its experimental drug, LMTX. The study failed, with patients on LMTX faring no better than those on placebo, but TauRX may [...]

Experimental Drug Dramatically Reduces Post-Partum Depression In Small Study

forbes.com — An experimental drug led to remission of post-partum depression in 7 of 10 patients, compared to 1 of 11 patients in a placebo group, boosting hope that the medicine might help women who become so distraught after childbirth that they need to be hospitalized. The drug, SAGE-547, had previously led to [...]

Theranos Defiantly Says Holmes Will Remain CEO, But It May Stop All Lab Operations

forbes.com — Elizabeth Holmes speaking at the Forbes Healthcare Summit last December. Credit: Glen Davis Theranos says that its founder, Elizabeth Holmes, will remain chief executive of the company despite sanctions from the Centers for Medicare & Medicaid Services. But the the blood testing startup admits that it may have to close all of [...]

Elizabeth Holmes Has Been Banned. What Does That Mean For Theranos?

forbes.com — Can Elizabeth Holmes, who Forbes once ranked as the richest self-made woman ever, even maintain control of the blood testing upstart she started? Last night, Holmes' company, Theranos, of which she is majority owner, announced that the Centers for Medicare & Medicaid Services will impose a raft of sanctions based on an [...]

Juno Therapeutics Stops Trial Of Cancer-Killing Cells After 3 Patient Deaths

forbes.com — Three patients have died in a closely watched study of using genetically engineered white blood cells to treat adult leukemia patients, forcing the trial to be put on hold. The news is a blow for Juno Therapeutics, the biotechnology startup valued at $4.3 billion that is developing the treatment, known as [...]

Obama Seeks To Make Mark On Genetic Medicine

forbes.com — After a few weeks of hype around the Obama administration's efforts to speed cancer research, officials tonight announced plans to kickstart efforts around the president's Precision Medicine Initiative.
More Articles →
Jul 30, 2016

RT @deborahblum: Meningitis outbreaks among gay men have experts puzzled  http://fw.to/25LcV0J 

Jul 29, 2016

@jetjocko @KatieMPalmer @WIRED it's a statement like "I believe in love." Love exists whether or not you believe. Science<>tinker bell

Jul 29, 2016

@roseperson @darth and then he realizes you'll do anything and put up with anything. He starts to like it.


Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.